Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) kicked off on Friday, up 0.92% from the previous trading day, before settling in for the closing price of $69.47. Over the past 52 weeks, BMRN has traded in a range of $67.75-$99.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 10.23%. While this was happening, its average annual earnings per share was recorded 131.66%. With a float of $187.97 million, this company’s outstanding shares have now reached $188.60 million.
Let’s determine the extent of company efficiency that accounts for 3401 employees. In terms of profitability, gross margin is 78.37%, operating margin of 8.59%, and the pretax margin is 11.53%.
Biomarin Pharmaceutical Inc. (BMRN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Biomarin Pharmaceutical Inc. is 1.27%, while institutional ownership is 100.09%. The most recent insider transaction that took place on Aug 13 ’24, was worth 64,260. In this transaction GVP, Chief Accounting Officer of this company sold 714 shares at a rate of $90.00, taking the stock ownership to the 14,449 shares. Before that another transaction happened on Aug 13 ’24, when Company’s Officer proposed sale 714 for $90.00, making the entire transaction worth $64,260.
Biomarin Pharmaceutical Inc. (BMRN) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported 0.21 earnings per share (EPS), lower than consensus estimate (set at 0.23) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 131.66% per share during the next fiscal year.
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Trading Performance Indicators
Take a look at Biomarin Pharmaceutical Inc.’s (BMRN) current performance indicators. Last quarter, stock had a quick ratio of 1.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.15. Likewise, its price to free cash flow for the trailing twelve months is 57.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.32, a number that is poised to hit 0.53 in the next quarter and is forecasted to reach 3.10 in one year’s time.
Technical Analysis of Biomarin Pharmaceutical Inc. (BMRN)
Looking closely at Biomarin Pharmaceutical Inc. (NASDAQ: BMRN), its last 5-days average volume was 1.2 million, which is a drop from its year-to-date volume of 1.86 million. As of the previous 9 days, the stock’s Stochastic %D was 66.30%. Additionally, its Average True Range was 1.54.
During the past 100 days, Biomarin Pharmaceutical Inc.’s (BMRN) raw stochastic average was set at 8.71%, which indicates a significant decrease from 74.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.43% in the past 14 days, which was lower than the 39.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $79.43, while its 200-day Moving Average is $84.18. However, in the short run, Biomarin Pharmaceutical Inc.’s stock first resistance to watch stands at $70.40. Second resistance stands at $70.68. The third major resistance level sits at $71.24. If the price goes on to break the first support level at $69.56, it is likely to go to the next support level at $69.00. Should the price break the second support level, the third support level stands at $68.72.
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Key Stats
The company with the Market Capitalisation of 13.35 billion has total of 189,880K Shares Outstanding. Its annual sales at the moment are 2,419 M in contrast with the sum of 167,650 K annual income. Company’s last quarter sales were recorded 712,030 K and last quarter income was 107,170 K.
